
Commentary|Videos|August 3, 2023
Public Misunderstandings Around Clinical Trials
Author(s)Lisa Henderson
"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals at DIA 2023.
Advertisement
"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals. And their answers span only a few of the challenges that remain in patient education and knowledge about the clinical research enterprise.
In this video, Kenneth Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development and Founder, Board Chair, CISCRP; Janice Chang, CEO of TransCelerate BioPharma, and Greg Ball, Safety Data Scientist and founder, ASAP Process Consulting present their views on the topic.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Execution Failures and Upstream Origins, European Data Governance Reshaping CROs, and Phase-Dependent Trial Competition
2
Real-World Evidence in Transition: CRO Adaptation to the European Health Data Space Framework
3
ACT Brief: Sponsor Oversight Capability Gaps, Community-Embedded Trial Partnerships, and Trialblazer Timeline Realism
4
The AI Churn Trap in Life Sciences and How to Break It
5




